FDA Approves Sitagliptin to Treat Type 2 Diabetes: Januvia's role in treatment is still unclear.

The newly licensed glucose-lowering agent sitagliptin phosphate appears safe and effective, but how and where it will fit into the armamentarium of treatment for type 2 diabetes is not yet clear.